CRDL
Price
$1.09
Change
-$0.03 (-2.68%)
Updated
Aug 28 closing price
Capitalization
91.39M
81 days until earnings call
LNTH
Price
$55.50
Change
-$1.34 (-2.36%)
Updated
Aug 28 closing price
Capitalization
3.77B
62 days until earnings call
Interact to see
Advertisement

CRDL vs LNTH

Header iconCRDL vs LNTH Comparison
Open Charts CRDL vs LNTHBanner chart's image
Cardiol Therapeutics
Price$1.09
Change-$0.03 (-2.68%)
Volume$945.42K
Capitalization91.39M
Lantheus Holdings
Price$55.50
Change-$1.34 (-2.36%)
Volume$1.06M
Capitalization3.77B
CRDL vs LNTH Comparison Chart in %
Loading...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRDL vs. LNTH commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDL is a StrongBuy and LNTH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CRDL: $1.09 vs. LNTH: $55.50)
Brand notoriety: CRDL and LNTH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRDL: 120% vs. LNTH: 62%
Market capitalization -- CRDL: $91.39M vs. LNTH: $3.77B
CRDL [@Pharmaceuticals: Generic] is valued at $91.39M. LNTH’s [@Pharmaceuticals: Generic] market capitalization is $3.77B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDL’s FA Score shows that 0 FA rating(s) are green whileLNTH’s FA Score has 0 green FA rating(s).

  • CRDL’s FA Score: 0 green, 5 red.
  • LNTH’s FA Score: 0 green, 5 red.
According to our system of comparison, LNTH is a better buy in the long-term than CRDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDL’s TA Score shows that 5 TA indicator(s) are bullish while LNTH’s TA Score has 5 bullish TA indicator(s).

  • CRDL’s TA Score: 5 bullish, 5 bearish.
  • LNTH’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LNTH is a better buy in the short-term than CRDL.

Price Growth

CRDL (@Pharmaceuticals: Generic) experienced а -6.84% price change this week, while LNTH (@Pharmaceuticals: Generic) price change was -6.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.61%. For the same industry, the average monthly price growth was +12.19%, and the average quarterly price growth was +85.29%.

Reported Earning Dates

CRDL is expected to report earnings on Nov 18, 2025.

LNTH is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LNTH($3.77B) has a higher market cap than CRDL($91.4M). CRDL YTD gains are higher at: -14.844 vs. LNTH (-37.961). LNTH has higher annual earnings (EBITDA): 457M vs. CRDL (-39.94M). LNTH has more cash in the bank: 696M vs. CRDL (18.2M). CRDL has less debt than LNTH: CRDL (143K) vs LNTH (615M). LNTH has higher revenues than CRDL: LNTH (1.52B) vs CRDL (0).
CRDLLNTHCRDL / LNTH
Capitalization91.4M3.77B2%
EBITDA-39.94M457M-9%
Gain YTD-14.844-37.96139%
P/E RatioN/A14.76-
Revenue01.52B-
Total Cash18.2M696M3%
Total Debt143K615M0%
FUNDAMENTALS RATINGS
CRDL vs LNTH: Fundamental Ratings
CRDL
LNTH
OUTLOOK RATING
1..100
5859
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
10061
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8791
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LNTH's Valuation (60) in the Medical Specialties industry is in the same range as CRDL (66) in the null industry. This means that LNTH’s stock grew similarly to CRDL’s over the last 12 months.

LNTH's Profit vs Risk Rating (61) in the Medical Specialties industry is somewhat better than the same rating for CRDL (100) in the null industry. This means that LNTH’s stock grew somewhat faster than CRDL’s over the last 12 months.

LNTH's SMR Rating (100) in the Medical Specialties industry is in the same range as CRDL (100) in the null industry. This means that LNTH’s stock grew similarly to CRDL’s over the last 12 months.

CRDL's Price Growth Rating (87) in the null industry is in the same range as LNTH (91) in the Medical Specialties industry. This means that CRDL’s stock grew similarly to LNTH’s over the last 12 months.

CRDL's P/E Growth Rating (100) in the null industry is in the same range as LNTH (100) in the Medical Specialties industry. This means that CRDL’s stock grew similarly to LNTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDLLNTH
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARRT0.20N/A
N/A
Artisan Consumer Goods, Inc.
CDIX1.50N/A
N/A
Cardiff Lexington Corporation
PTAIF0.31N/A
N/A
PT Astra International
SEIGF15.96N/A
N/A
Semperit Ag Holding
HKUOF7.02N/A
N/A
Hakuhodo Dy Holdings, Inc.

CRDL and

Correlation & Price change

A.I.dvisor tells us that CRDL and ACB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
-2.68%
ACB - CRDL
32%
Poorly correlated
+5.44%
EOLS - CRDL
29%
Poorly correlated
-0.79%
LNTH - CRDL
28%
Poorly correlated
-2.36%
OGI - CRDL
28%
Poorly correlated
+3.59%
SCYX - CRDL
25%
Poorly correlated
+1.76%
More

LNTH and

Correlation & Price change

A.I.dvisor tells us that LNTH and EOLS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LNTH and EOLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
-2.36%
EOLS - LNTH
33%
Poorly correlated
-0.79%
ACET - LNTH
32%
Poorly correlated
+0.40%
CRDL - LNTH
28%
Poorly correlated
-2.68%
SNDL - LNTH
26%
Poorly correlated
+6.32%
LFCR - LNTH
24%
Poorly correlated
+1.20%
More